Pfizer (PFE) Not Up On Viagra

Print Email

A Canadian court ruled that Apotex could not market a generic version of Viagra, Pfizer’s (PFE) massively successful ED drug. Oddly, Pfizer’s shares were down 1.2% to $24.35.

The Big Pharma company has watched its stock slide almost 15% as generic drugs continue to lay siege to sales of some of its most important drugs.

Douglas A. McIntyre